300685.SZ SHZ
Amoy Diagnostics Co., Ltd.
1W: +7.1%
1M: +23.1%
3M: +20.3%
YTD: +0.5%
1Y: -8.7%
3Y: -7.2%
5Y: -59.9%
¥21.34 ($3.18)
+0.34 (+1.62%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$1.2B
+8.0% ▲
5Y CAGR: +10.5%
Gross Profit
$0
-100.0% ▼
Operating Income
$418M
+42.6% ▲
5Y CAGR: +15.6%
Net Income
$358M
+40.4% ▲
5Y CAGR: +14.7%
EPS (Diluted)
$0.90
+40.6% ▲
5Y CAGR: +14.9%
EBITDA
$418M
+23.7% ▲
5Y CAGR: +15.5%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $917M | $842M | $1.0B | $1.1B | $1.2B |
| YoY Growth | +25.9% | -8.2% | +23.9% | +6.3% | +8.0% |
| Cost of Revenue | $147M | $153M | $177M | $181M | $0 |
| Gross Profit | $770M | $689M | $867M | $928M | $0 |
| Gross Margin | 83.9% | 81.8% | 83.0% | 83.6% | 0.0% |
| R&D Expenses | $127M | $175M | $203M | $216M | $0 |
| SG&A Expenses | $364M | $360M | $385M | $419M | $0 |
| Operating Expenses | $517M | $401M | $565M | $635M | $780M |
| Operating Income | $253M | $288M | $301M | $293M | $418M |
| Operating Margin | 27.6% | 34.2% | 28.9% | 26.4% | 34.9% |
| Interest Expense | $801K | $1M | $2M | $2M | $0 |
| Income Before Tax | $252M | $286M | $295M | $290M | $411M |
| Tax Expense | $13M | $22M | $33M | $35M | $0 |
| Net Income | $240M | $264M | $261M | $255M | $358M |
| Net Margin | 26.1% | 31.3% | 25.1% | 23.0% | 29.9% |
| EPS (Diluted) | $0.60 | $0.67 | $0.66 | $0.64 | $0.90 |
| EBITDA | $271M | $191M | $322M | $323M | $418M |
| Shares Outstanding | 399M | 394M | 396M | 398M | 398M |